Pazopanib in combination with interferon alpha 2A
Showing 1 - 25 of >10,000
Advanced Renal Cell Carcinoma Trial in Spain (Pazopanib + interferon alpha 2A)
Completed
- Advanced Renal Cell Carcinoma
- Pazopanib + interferon alpha 2A
-
Hospitalet de Llobregat, Barcelona, Spain
- +12 more
Mar 9, 2022
HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1
Recruiting
- HLA-A2 Positive Cells Present
- Refractory Melanoma
- Alpha-type-1 Polarized Dendritic Cells
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 12, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Unresectable Triple-Negative Breast
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Biopsy
- +7 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Feb 23, 2023
Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)
Recruiting
- Polycythemia Vera
- Ruxolitinib
- Pegylated interferon α-2b
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
May 19, 2023
Myelofibrosis Trial in Salt Lake City (Pegylated interferon alpha2a)
Not yet recruiting
- Myelofibrosis
- Pegylated interferon alpha2a
-
Salt Lake City, UtahHuntsman Cancer Institute at the University of Utah
Sep 6, 2022
Sarcoma, Kaposi, HIV Trial in Miami (Interferon alfa-2a, Zidovudine, Interferon alfa-n1)
Completed
- Sarcoma, Kaposi
- HIV Infections
- Interferon alfa-2a
- +2 more
-
Miami, FloridaUniv of Miami School of Medicine
Oct 27, 2021
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- Best Practice
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Mar 1, 2022
Hepatitis B, Chronic Trial in Hefei (PEGylated recombinant human interferon alpha-2b injection)
Recruiting
- Hepatitis B, Chronic
- PEGylated recombinant human interferon alpha-2b injection
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of Anhui Medical University
Jun 24, 2023
Sarcoma, Kaposi, HIV Trial in New York (Interferon alfa-2a, Zidovudine, Interferon alfa-n1)
Completed
- Sarcoma, Kaposi
- HIV Infections
- Interferon alfa-2a
- +2 more
-
New York, New YorkMem Sloan - Kettering Cancer Ctr
Oct 28, 2021
Chronic Hepatitis B Trial in Worldwide (VIR-2218, pegylated interferon-alfa 2a)
Active, not recruiting
- Chronic Hepatitis B
- VIR-2218
- pegylated interferon-alfa 2a
-
Birtinya, Queensland, Australia
- +21 more
Dec 20, 2021
Herpes Zoster Trial (Recombinant Human Interferon a-2b Gel (After the Alteration), Recombinant Human Interferon a-2b Gel (Before
Not yet recruiting
- Herpes Zoster
- Recombinant Human Interferon α-2b Gel (After the Alteration)
- Recombinant Human Interferon α-2b Gel (Before the Alteration)
- (no location specified)
Apr 7, 2023
Essential Thrombocytopenia Trial in Tianjin (Recombinant Interferon Alpha, Pegylated interferon alfa-2b)
Recruiting
- Essential Thrombocytopenia
- Recombinant Interferon Alpha
- Pegylated interferon alfa-2b
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Jul 18, 2022
Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma, Advanced Squamous Cell Carcinoma Trial in Miami (Cemiplimab-Rwlc,
Not yet recruiting
- Cutaneous Squamous Cell Carcinoma
- +2 more
- Cemiplimab-Rwlc
- PEG-IFN alfa-2a
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Feb 6, 2023
Glioblastoma Multiforme Trial in Nice (Pazopanib)
Active, not recruiting
- Glioblastoma Multiforme
-
Nice, Cedex 2, FranceCentre Antoine Lacassagne
Mar 3, 2022
Hepatitis B, Chronic Trial in Hong Kong, Korea, Republic of, Taiwan (EYP001a, Entecavir, Pegylated interferon alpha2a)
Active, not recruiting
- Hepatitis B, Chronic
- EYP001a
- +2 more
-
Hong Kong, Hong Kong
- +5 more
Sep 27, 2021
Coronavirus Disease 2019 Trial in Santiago (Interferon-Alpha2B, Placebo)
Completed
- Coronavirus Disease 2019
- Interferon-Alpha2B
- Placebo
-
Santiago, RM, ChileRed de Salud UC Christus
Aug 3, 2022
Breast Carcinoma Trial in Houston (biological, drug, other)
Not yet recruiting
- Breast Carcinoma
- eftilagimod alpha
- +2 more
-
Houston, TexasOncology Consultants
Feb 17, 2023
Metastatic Carcinoma in the Liver, Recurrent Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in Buffalo (drug,
Completed
- Metastatic Carcinoma in the Liver
- +4 more
- Celecoxib
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Feb 25, 2022
COVID-19 Infection and Its Clinical Prognosis in Chronic
Recruiting
- Chronic Hepatitis B
- COVID-19 Infection
- Interferon
- nucleoside analogues
-
Beijing, Beijing, ChinaDepartment of Hepatology Division 2, Beijing Ditan Hospital
Mar 28, 2023
Hepatitis B, Chronic Trial in Shanghai (hepalatide, Pegylated Interferon, TAF)
Not yet recruiting
- Hepatitis B, Chronic
- hepalatide
- +3 more
-
Shanghai, Shanghai, ChinaShanghai Tong Ren Hospital
Nov 12, 2021
Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma
Recruiting
- Stage III Hepatocellular Carcinoma AJCC v8
- +6 more
- Fluorouracil
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 18, 2021
Diabetic Neuropathies, Diabetes, Dietary Supplement Trial in Thessaloníki (Epineuron, Placebo group)
Completed
- Diabetic Neuropathies
- +2 more
- Epineuron
- Placebo group
-
Thessaloníki, Thessaloniki, GreeceUniversity General Hospital AHEPA
Aug 8, 2023
Sarcoma, Kaposi, HIV Trial in United States (Interferon alfa-2a, Zidovudine)
Completed
- Sarcoma, Kaposi
- HIV Infections
- Interferon alfa-2a
- Zidovudine
-
Miami, Florida
- +8 more
Oct 26, 2021